Melibiose

Melibiose

SCHEMBL21114348

OC[C@H]1O[C@H](OC[C@H]2O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O.OC[C@H]1O[C@H](OC[C@H]2O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.61
CA2 P00918 2/20 0.59
CDK1 P06493 1/20 0.57
CCNB1 P14635 1/20 0.57
ACHE P22303 1/20 0.50
CD209 Q9NNX6 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.46
AMY2A P04746 2/20 0.45
TYR P14679 1/20 0.45
MAPT P10636 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA9 Q16790 1/20 0.44
LGALS8 O00214 1/20 0.44
LGALS3 P17931 1/20 0.44
LGALS4 P56470 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Melibiose SCHEMBL4257775 1.00 GAA (0.61) GAACA2CDK1CCNB1ACHE
Melibiose SCHEMBL20421903 1.00 GAA (0.61) GAACA2CDK1CCNB1ACHE
Melibiose SCHEMBL21356838 1.00 GAA (0.61) GAACA2CDK1CCNB1ACHE
SCHEMBL18650670 1.00 GAA (0.61) GAACA2CDK1CCNB1ACHE
Melibiose SCHEMBL2354450 1.00 GAA (0.61) GAACA2CDK1CCNB1ACHE
Melibiose SCHEMBL109659 1.00 GAA (0.61) GAACA2CDK1CCNB1ACHE
Melibiose SCHEMBL24013212 1.00 GAA (0.61) GAACA2CDK1CCNB1ACHE
Melibiose SCHEMBL21356841 1.00 GAA (0.61) GAACA2CDK1CCNB1ACHE
Melibiose SCHEMBL21356840 1.00 GAA (0.61) GAACA2CDK1CCNB1ACHE
Melibiose SCHEMBL1782423 1.00 GAA (0.61) GAACA2CDK1CCNB1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190214145-A1 Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen KUREK ITZHAK (US) 2019-07-11 US disclosed